The dangers of unopposed beta-adrenergic blockade in phaeochromocytoma.

The dangers of unopposed beta-adrenergic blockade in phaeochromocytoma.

Detalhes bibliográficos
Main Authors:	Sheaves, R, Chew, S, Grossman, AB
Formato:	Journal article
Idioma:	English
Publicado em:	1995

Registos relacionados

Beta adrenergic blockade reduces utilitarian judgement.
Por: Terbeck, S, et al.
Publicado em: (2013)

Combined blockade of signalling pathways shows marked anti-tumour potential in phaeochromocytoma cell lines.
Por: Nölting, S, et al.
Publicado em: (2012)

Beta adrenergic blockade reduces utilitarian judgement (vol 92, pg 323, 2013)
Por: Terbeck, S, et al.
Publicado em: (2014)

Beta adrenergic blockade reduces utilitarian judgment (vol 92, pg 323, 2013)
Por: Sylvia, T, et al.
Publicado em: (2014)

Beta-adrenergic agonists and corticotropin secretion.
Por: Al-Damluji, S, et al.
Publicado em: (1985)

Integrated response to exercise in patients with hypertrophic obstructive cardiomyopathy and effect of beta-adrenergic blockade on oxygen transport.
Por: Edwards, R, et al.
Publicado em: (1969)

INTEGRATED RESPONSE TO EXERCISE IN PATIENTS WITH HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY AND EFFECT OF BETA-ADRENERGIC BLOCKADE ON OXYGEN TRANSPORT
Por: Edwards, R, et al.
Publicado em: (1969)

The diagnosis and management of malignant phaeochromocytoma and paraganglioma.
Por: Chrisoulidou, A, et al.
Publicado em: (2007)

Corrigendum to Beta adrenergic blockade reduces utilitarian judgment [Biol. Psychol. 92 (2) (2013) 323-328]
Por: Sylvia, T, et al.
Publicado em: (2014)

Combined Blockade of Several Signalling Pathways Shows Marked Anti-Tumor Potential in Two Novel Mouse Phaeochromocytoma Cell Lines
Por: Noelting, S, et al.
Publicado em: (2012)

Beta adrenergic blokade in myocardial infarction
Por: Yusuf, S
Publicado em: (1980)

Phaeochromocytoma crisis presenting with profound hypoglycaemia and subsequent hypertension.
Por: Frankton, S, et al.
Publicado em: (2009)

MIBG scans for phaeochromocytoma: time to abandon the technique?
Por: Grossman, A, et al.
Publicado em: (2009)

Naloxone provokes catecholamine release in phaeochromocytomas and paragangliomas.
Por: Bouloux, P, et al.
Publicado em: (1986)

The effect of exogenous glucocorticoids on plasma catecholamines and metanephrines in patients without phaeochromocytomas.
Por: Druce, MR, et al.
Publicado em: (2011)

The Effect of Exogenous Glucocorticoids on Plasma Catecholamines and Metanephrines in Patients Without Phaeochromocytomas
Por: Druce, MR, et al.
Publicado em: (2012)

Bilateral phaeochromocytomas in von Hippel-Lindau disease: diagnosis by adrenal vein sampling and catecholamine assay.
Por: Chew, S, et al.
Publicado em: (1994)

The use of venous catheterization in the diagnosis and localization of bilateral phaeochromocytomas.
Por: Newbould, E, et al.
Publicado em: (1991)

The clinical presentation (symptoms and signs) of sporadic and familial chromaffin cell tumours (phaeochromocytomas and paragangliomas).
Por: Kaltsas, G, et al.
Publicado em: (2004)

Study of Beta 2-Adrenergic Receptor Polymorphisms among Hypertensives
Por: Atia, Ahmad Elbadry, et al.
Publicado em: (2010)

Beta-adrenergic stimulation and cardiac arrhythmogenesis in the infarct border zone
Por: Tomek, J
Publicado em: (2017)

Single molecule fluorescent studies of immobilized beta(2)-adrenergic receptor
Por: Huang, B, et al.
Publicado em: (2003)

Early intravenous beta-blockade in myocardial infarction.
Por: Sleight, P, et al.
Publicado em: (1982)

Treatment of malignant phaeochromocytoma, paraganglioma and carcinoid tumours with 131I-metaiodobenzylguanidine.
Por: Bomanji, J, et al.
Publicado em: (1993)

Mechanism of heart failure resulting from chronic beta-adrenergic stimulation
Por: Carr, C, et al.
Publicado em: (2004)

Novel and evolving therapies in the treatment of malignant phaeochromocytoma: experience with the mTOR inhibitor everolimus (RAD001).
Por: Druce, MR, et al.
Publicado em: (2009)

Beta−Adrenergic Stimulation Maintains Cardiac Function in Serca2 Knockout Mice
Por: Land, S, et al.
Publicado em: (2013)

Enhancement of beta adrenergic responsiveness in myocytes lacking nitric oxide synthase 1
Por: Ashley, E, et al.
Publicado em: (2001)

Dopamine-secreting phaeochromocytomas and paragangliomas: clinical features and management
Por: Foo, S.H., et al.
Publicado em: (2010)

Observation of beta(2)-adrenergic receptor activation using a photon counting histogram
Por: Perroud, T, et al.
Publicado em: (2003)

The Involvement of NAADP and Two-Pore Ca2+ Channels in the Cardiac Beta-Adrenergic Response
Por: Bolton, E, et al.
Publicado em: (2013)

Effects of beta-adrenoceptor blockade on components of human decision-making.
Por: Rogers, R, et al.
Publicado em: (2004)

The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk.
Por: Key, T, et al.
Publicado em: (1988)

123I-metaiodobenzylguanidine (MIBG) scintigraphy for the detection of adrenal and extra-adrenal phaeochromocytomas: CT and MRI correlation.
Por: Bhatia, K, et al.
Publicado em: (2008)

Acute changes of myocardial creatine kinase gene expression under beta-adrenergic stimulation.
Por: Hammerschmidt, S, et al.
Publicado em: (2000)

Effects of beta-2 adrenergic receptor agonists in DOK7 congenital myasthenic syndrome
Por: Clausen, L
Publicado em: (2015)

Myocardial NOS1 controls the lusitropic response to beta-adrenergic stimulation in vivo and in vitro
Por: Sears, C, et al.
Publicado em: (2003)

Genetic analysis of mitochondrial complex II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibility.
Por: Astuti, D, et al.
Publicado em: (2003)

Clinical manifestations of familial paraganglioma and phaeochromocytomas in succinate dehydrogenase B (SDH-B) gene mutation carriers.
Por: Srirangalingam, U, et al.
Publicado em: (2008)

Slowing the heart saves lives: advantages of perioperative beta-blockade.
Por: Higham, H, et al.
Publicado em: (2000)